Alkem Laboratories Ltd.

ALKEM

Market Cap
₹61,977 Cr.
P/E
39.40

Alkem Laboratories Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
10.88%
3yr Average
17.14%
5yr Average
16.74%
Net Profit Margin
Latest
8.48%
3yr Average
13.95%
5yr Average
13.14%
ROCE
Latest
17.32%
3yr Average
23.09%
5yr Average
22.27%
Debt to Equity
Latest
0.14
3yr Average
0.22
5yr Average
0.22
Market Share
2% (as of Jul 22)
Anti - Diabetes - Market Share
9.27% (as of Jul 22)
Anti-Infectives - Market Share
0.04% (as of Jul 20)
Anti-Malarial - Market Share
0.37% (as of Nov 21)
Antineo Plastic - Market Share
0.03% (as of May 19)
Blood Related - Market Share
0.95% (as of Jul 22)
Cardiovascular - Market Share
2.02% (as of Nov 21)
Dermatology - Market Share
1% (as of Nov 21)
Endocrinology - Market Share
5.61% (as of Jul 22)
Gastro-Intestinal - Market Share
1.09% (as of Nov 21)
Gynecology - Market Share
3.14% (as of Nov 21)
Neurological - Market Share
0.01% (as of Nov 21)
Ophthalmology - Market Share
3.32% (as of Nov 21)
Pain - Market Share
4% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.96% (as of Nov 21)
Respiratory - Market Share
0.02% (as of Jul 22)
Sex Stimulants - Market Share
0.01% (as of May 20)
Stomatological - Market Share
0.98% (as of Nov 21)
Urology - Market Share
4.89% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up -India

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Australia
      Source
    • Number of ANDA's Approved by Australia
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Clavam
    Taxim
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Alkem Laboratories Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline